Resources>Blog>AI and Computational Approaches in Antibody Research

AI and Computational Approaches in Antibody Research

Biointron 2024-01-24 Read time: 1 min
AI.jpg
Image credit: DOI: 10.3390/ijerph18010271

Artificial intelligence (AI) and computational methods are a powerful tool for antibody discovery and engineering. Despite historical prevalence in small molecule-related applications, AI is progressively being utilized in the discovery and advancement of therapeutic antibodies, backed by the surge in computational power and innovative algorithms, with an increasing amount of data obtained through next-generation sequencing and related drug modalities such as VHH antibodies.1

The main uses of these approaches in antibody research involve2

These computational methods can provide much more cost-efficient and rapid turnaround time compared to the laborious experimental methods that are common in antibody discovery. Escalating costs are often a significant impediment to the advancement of drug discovery.


At Biointron, we are dedicated to accelerating your antibody discovery, optimization, and production needs. Our team of experts can provide customized solutions that meet your specific research needs. Contact us to learn more about our services and how we can help accelerate your research and drug development projects.


References:

  1. Norman, R. A., Ambrosetti, F., Bonvin, A. M., Colwell, L. J., Kelm, S., Kumar, S., & Krawczyk, K. (2020). Computational approaches to therapeutic antibody design: Established methods and emerging trends. Briefings in Bioinformatics, 21(5), 1549-1567. https://academic.oup.com/bib/article/21/5/1549/5581643

  2. Kim, J., McFee, M., Fang, Q., Abdin, O., & Kim, P. M. (2023). Computational and artificial intelligence-based methods for antibody development. Trends in Pharmacological Sciences, 44(3), 175–189. https://www.cell.com/trends/pharmacological-sciences/fulltext/S0165-6147(22)00279-6


Subscribe to our Blog
Recommended Articles
Next-Generation Antibody Conjugates for Targeted Anticancer Drug Delivery

In this article, we explore the major trends shaping the future of targeted canc……

May 29, 2026
Site-Specific Conjugation Strategies for Next-Generation Antibody-Drug Conjugates

Site-specific conjugation limits payload attachment to defined positions on the ……

May 27, 2026
How Surface Patches Shape Antibody Specificity and Developability

Affinity maturation can improve binding to the intended target, but it can also ……

May 25, 2026
XDCs: The Evolution of Antibody-Drug Conjugates

ADC development is no longer limited to the antibody-linker-toxin model. The fie……

May 23, 2026

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.